Cargando…
The efficacy of dapagliflozin for type 1 diabetes: a meta-analysis of randomized controlled studies
INTRODUCTION: The efficacy of dapagliflozin for type 1 diabetes remains controversial. We conduct a systematic review and meta-analysis to explore the treatment efficacy of dapagliflozin versus placebo in patients with type 1 diabetes. METHODS: We have searched PubMed, EMbase, Web of science, EBSCO...
Autores principales: | Ma, Jian, Zhao, Yanhong, Fan, Huihui, Liu, Jia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Makerere Medical School
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356594/ https://www.ncbi.nlm.nih.gov/pubmed/34394274 http://dx.doi.org/10.4314/ahs.v21i1.2 |
Ejemplares similares
-
Efficacy and safety of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: A meta-analysis of randomized controlled trials
por: Huang, Yuxin, et al.
Publicado: (2021) -
Effects of dapagliflozin in the progression of atherosclerosis in patients with type 2 diabetes: a meta-analysis of randomized controlled trials
por: Wu, Qian-Long, et al.
Publicado: (2022) -
The efficacy of dapagliflozin combined with hypoglycemic drugs in treating type 2 diabetes: protocol for meta-analysis of randomized controlled trials
por: Sun, Yu-nan, et al.
Publicado: (2013) -
Efficacy and safety of dapagliflozin as monotherapy in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials
por: Feng, Miao, et al.
Publicado: (2019) -
A Network Meta-Analysis of the Dose–Response Effects of Dapagliflozin on Efficacy and Safety in Adults With Type 1 Diabetes
por: Li, Yinhui, et al.
Publicado: (2022)